NewsDesk @bactiman63 Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the...

NewsDesk @bactiman63 University of Oklahoma and Baylor College of Medicine researchers are investigating a potential treatment for a disease that affects as many as 8 million people in the United States...

NewsDesk @bactiman63 The Pan American Health Organization (PAHO) said on Thursday, April 14, or World Chagas Disease Day, due to its silent nature, less than 10% of those infected with Chagas disease...

A clinical trial has been launched in Argentina to see if a shorter regimen of the drug benznidazole has the potential to become a new standard treatment for Chagas disease to treat adult patients in the...

By NewsDesk  @infectiousdiseasenews In search of treatment for Chagas disease, which kills thousands each year, Cal State Fullerton infectious disease researchers have discovered an important new mechanism...

Animal toxins are research targets owing to their therapeutic and biotechnological potential. Researchers at the Federal University of the ABC (UFABC), Federal University of São Paulo (UNIFESP) and Federal...

Chagas disease is a potentially life-threatening parasitic disease that affects  up to 300,000 people in the United States and millions in South America. The current treatment regimen is–oral benznidazole...

By NewsDesk  @bactiman63 Researchers in the University of Georgia’s Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently...

Chagas disease is a parasitic disease caused by Trypanosoma cruzi. It is found mainly in endemic areas of 21 Latin American countries where infection is transmitted mostly by vectors to humans by contact...

California based biopharmaceutical company, KaloBios Pharmaceuticals, Inc. yesterday announced positive guidance in the minutes from a recent meeting with the U.S. Food and Drug Administration (FDA) to...